BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-9563 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-9563\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07297797-564@assetmemo.bio
DTSTAMP:20261121T005651Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS-9563: Phase 2 readout est. (NCT07297797)
DESCRIPTION:HRS-9563\, phase 2\, Hypertension.\nStudy: Phase II Clinical St
 udy of HRS-9563 in Patients With Mild to Moderate Hypertension\nEstimated 
 primary completion: December 2026. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/hrs-9563#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07297797
URL:https://assetmemo.bio/drug/hrs-9563#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
